Occupation: Director and Scientific Advisor
Company: Catalent
Born: Chile
Education:
MSc, Biochemistry and Molecular Biology, Universidad Austral de Chile (1994)
Bachelor’s Degree, Instituto Salesiano (1987)
Career:
Director, Scientific Advisor, Catalent, Kansas City, MO (2025-Present)
Biologics Manager, Catalent (2020-Present)
Biologics Group Leader, Catalent, Kansas City, MO (2016-Present)
Director, Biologics, Catalent, Kansas City, MO (2021-2025)
Senior Scientist, Catalent, Kansas City, MO (2012-2016)
Scientist, Aptuit, Kansas City, MO (2007-2012)
Senior Scientist, The University of Kansas Cancer Center (2009-2010)
Senior Research Associate, University of Kansas Medical Center (1998-2007)
Research Assistant, University of Missouri-Kansas City (1995-1998)
Student, Universidad Austral de Chile (1988-1994)
Civic:
Speaker, Biopharmaceutical Emerging Best Practice Association (BEBPA)
Creative Works:
Co-author, “Leveraging Novel Analytical Approaches for Advanced Therapies,” Catalent (2023); Co-author, “Development and Characterization of a Novel C-terminal Inhibitor of Hsp90 in Androgen Dependent and Independent Prostate Cancer Cells, BMC Cancer (2011); Co-author, “Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 Homodimers in Human Placental Villous Cytotrophoblast Cells,” Immunology (2007); Co-author, “A Commentary on Gestational Programming and Functions of HLA-G in Pregnancy,” Placenta (2007); Co-author, “Polymorphisms in Paan-AG Promoter Influences NF-?B Binding and Transcription Activity in HEK293 cells (42.12),” The Journal of Immunology (2007); Co-author, “The Role of HLA-G in Human Pregnancy,” Reproductive Biology and Endocrinology (2006); Co-author, “Analysis of the Soluble Isoforms of HLA-G mRNAs and Proteins,” Methods Mol Med. (2006); Co-author, “Recombinant HLA-G5 and -G6 drive U937 Myelomonocytic Cell Production of TGF-beta1,” J Leukoc Biol. (2004); Co-author, “Placental Cell Expression of HLA-G2 Isoforms is Limited to the Invasive Trophoblast Phenotype,” J. Immunol (2003); Co-author, “Immunogenicity of the Soluble Isoforms of HLA-G,” Molecular Human Reproduction (2003); Co-author, “Baboon Placentas Express Soluble and Membrane-bound Paan-AG Proteins Encoded by Alternatively Spliced Transcripts of the class Ib Major Histocompatibility Complex Gene, Paan-AG,” Immunogenetics (2002); Co-author, “Cell-surface Events for metallothionein-1 and heme oxygenase-1 Regulation by the hemopexin-heme transport system,” Antioxid Redox Signal (2000); Co-author, “Role for Copper in Transient Oxidation and Nuclear Translocation of MTF-1, but not of NF- kappa B, by the heme-hemopexin transport system,” Antioxid Redox Signal (2000); Co-author, “Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase,” J Biol Chem (1999); Co-author, “Identification of a Renibacterium salmoninarum DNA fragment associated with bacterial internalization into CHSE-cultured cells,” FEMS Microbiol Lett (1996); Co-author, “Development And NDA-Level Validation Of A Real-Time PCR Procedure,” Catalent
Achievements:
Patent: (WO/2002/022784) Expression, Preparation, Uses, and Sequence of Recombinantly-Derived Soluble HLA-G) (WO/2002/022784) (2001)
Awards:
Recipient, Outstanding Award, Catalent (2023)
Memberships:
Recipient, The American Association of Immunologists (2005-Present)
Hobbies:
Enjoying nature; Traveling; Nutrition; Sports; Keeping himself in shape